Encochleated docetaxel - Matinas BioPharma
Alternative Names: LNC-docetaxelLatest Information Update: 18 Apr 2024
At a glance
- Originator Matinas BioPharma
- Class Antineoplastics; Radiopharmaceutical diagnostics; Small molecules; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer